These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18853319)

  • 1. Comparison of topical and intravenous administration of WIN 55-212-2 in normotensive rabbits.
    Samudre SS; Schneider JL; Oltmanns MH; Hosseini A; Pratap K; Loose-Thurman P; Allen RC; Williams PB; Lattanzio FA; Sheppard JD
    Curr Eye Res; 2008 Oct; 33(10):857-63. PubMed ID: 18853319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.
    Oltmanns MH; Samudre SS; Castillo IG; Hosseini A; Lichtman AH; Allen RC; Lattanzio FA; Williams PB
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):104-15. PubMed ID: 18201139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.
    Szczesniak AM; Maor Y; Robertson H; Hung O; Kelly ME
    J Ocul Pharmacol Ther; 2011 Oct; 27(5):427-35. PubMed ID: 21770780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic topical administration of WIN-55-212-2 maintains a reduction in IOP in a rat glaucoma model without adverse effects.
    Hosseini A; Lattanzio FA; Williams PB; Tibbs D; Samudre SS; Allen RC
    Exp Eye Res; 2006 May; 82(5):753-9. PubMed ID: 16289049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Topical Bimatoprost 0.01% and Timolol 0.5% on Circadian IOP, Blood Pressure and Perfusion Pressure in Patients with Glaucoma or Ocular Hypertension: A Randomized, Double Masked, Placebo-Controlled Clinical Trial.
    Oddone F; Rossetti L; Tanga L; Berardo F; Ferrazza M; Michelessi M; Roberti G; Manni G; Centofanti M
    PLoS One; 2015; 10(10):e0140601. PubMed ID: 26484767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs.
    Plummer CE; MacKay EO; Gelatt KN
    Vet Ophthalmol; 2006; 9(4):245-9. PubMed ID: 16771760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence against cannabinoid receptor involvement in intraocular pressure effects of cannabinoids in rabbits.
    Hodges LC; Reggio PH; Green K
    Ophthalmic Res; 1997; 29(1):1-5. PubMed ID: 9112260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The In Vivo Effects of the CB
    Cairns EA; Szczesniak AM; Straiker AJ; Kulkarni PM; Pertwee RG; Thakur GA; Baldridge WH; Kelly MEM
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):582-590. PubMed ID: 28719234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
    Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys.
    Chien FY; Wang RF; Mittag TW; Podos SM
    Arch Ophthalmol; 2003 Jan; 121(1):87-90. PubMed ID: 12523891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The determination of additive effect and intraocular pressure lowering effects of 0.05% bromocriptine and 0.25% timolol.
    Elibol O; Güler C; Arici K; Topalkara A; Demircan S
    Int Ophthalmol; 1996-1997; 20(1-3):53-5. PubMed ID: 9112164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of topical administration of latanoprost, timolol, or a combination of latanoprost and timolol on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
    Smith LN; Miller PE; Felchle LM
    Am J Vet Res; 2010 Sep; 71(9):1055-61. PubMed ID: 20807145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of separate and combined topical treatment with timolol maleate and trifluormethazolamide on the intraocular pressure in normal rabbits.
    Bar-Ilan A
    Curr Eye Res; 1984 Nov; 3(11):1305-12. PubMed ID: 6542484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of topical timolol on tissue circulation in optic nerve head.
    Tamaki Y; Araie M; Tomita K; Tomidokoro A
    Jpn J Ophthalmol; 1997; 41(5):297-304. PubMed ID: 9363557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of trabeculectomy with topically applied timolol in a rabbit ocular hypertension model.
    Lu DW; Chiang CH; Shang ST; Chou PI
    J Ocul Pharmacol Ther; 1998 Aug; 14(4):323-9. PubMed ID: 9715435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced ocular hypotensive response to timolol in rabbits with prior dexamethasone treatment.
    Schwartz B; Rom ME
    J Ocul Pharmacol Ther; 2001 Feb; 17(1):27-33. PubMed ID: 11322635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of timolol and UF-021 (a prostaglandin-related compound) on pulsatile ocular blood flow in normal volunteers.
    Kitaya N; Yoshida A; Ishiko S; Mori F; Abiko T; Ogasawara H; Kato Y; Nagaoka T
    Ophthalmic Res; 1997; 29(3):139-44. PubMed ID: 9211466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of topical application of timolol and verapamil in patients with glaucoma within 6 months.
    Shayegan MR; Boloorian AA; Kianoush S
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):551-3. PubMed ID: 20028263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a dorzolamide/timolol fixed combination on diurnal intraocular pressure, heart rate, blood pressure, and ocular perfusion pressure in normal-tension glaucoma.
    Lee NY; Park HY; Park CK
    Jpn J Ophthalmol; 2016 Sep; 60(5):377-82. PubMed ID: 27312903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure.
    Seibold LK; DeWitt PE; Kroehl ME; Kahook MY
    J Ocul Pharmacol Ther; 2017 Apr; 33(3):161-169. PubMed ID: 28129020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.